We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
U.S. index futures indicate a positive opening in Monday’s pre-market, extending the robust gains achieved last week. At 06:36 AM, the futures for the Dow Jones Industrial Average...
Total 1Q 2024 net product revenue of $75.0 million, representing 160% year-over-year growth Auvelity® 1Q 2024 net product sales of $53.4 million, representing 240% year-over-year growth Sunosi®...
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
AXS-05 in Alzheimer’s disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in pooled analysis Presentations on cognitive and wake...
NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.67 | 0.893214238102 | 75.01 | 77.98 | 73.31 | 753138 | 75.83856852 | CS |
4 | 4.57 | 6.42666291661 | 71.11 | 77.98 | 65.5 | 601025 | 72.17477684 | CS |
12 | -19.32 | -20.3368421053 | 95 | 95.25 | 65.5 | 750911 | 75.97589365 | CS |
26 | 14.46 | 23.6197321137 | 61.22 | 98.4 | 55.02 | 694882 | 76.88205928 | CS |
52 | -2.05 | -2.63733436254 | 77.73 | 98.4 | 55.02 | 742075 | 75.10963495 | CS |
156 | 20.32 | 36.7052023121 | 55.36 | 98.4 | 19.38 | 975912 | 53.89568462 | CS |
260 | 57.01 | 305.356186395 | 18.67 | 125.25 | 13.64 | 880324 | 54.93204588 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions